AstraZeneca (AZN) volatility elevated into shares selling off on failed drug trial
Tweet
Share
E-mail
Get Alerts AZN Hot Sheet
Join SI Premium – FREE
AstraZeneca (NYSE: AZN) July call option implied volatility is at 100, August is at 53; compared to its 52-week range of 20 to 57 into a failed drug trial.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Criteo Is Said To Attract Vista Equity-backed Takeover Offer - Bloomberg
- Western Union (WU) 9400 contracts of January 10 calls trade
- Trump: Walmart will be lowering prices
Create E-mail Alert Related Categories
Options, Trader TalkRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
